fasudil Articles
Actelion to appeal even though US court cuts original verdict by nearly $170 million in dispute with Asahi
21 November 2011
Actelion granted motion for new trial in Asahi damages dispute
24 October 2011
Showing 1-3 of 3 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
